CA-NTT
19.5.2020 00:02:12 CEST | Business Wire | Press release
The University of California, Berkeley and NTT Corporation (NTT) today announced a connected campus pilot project that will leverage technology to transform the UC Berkeley Parking and Transportation Department by analyzing patterns, easing traffic congestion and increasing pedestrian safety in the Bancroft Way area of campus.
The pilot will incorporate NTT’s Accelerate Smart data platform and Dell Technologies’ modular data center infrastructure for edge deployments of high-definition optical sensors and IoT devices that monitor traffic-related issues. These smart technologies will provide data to facilitate enhanced traffic management and mobility. As a first step in their “Connected Campus” initiative, UC Berkeley will leverage vehicle counting and classification to make informed decisions and develop specific solutions.
“At Berkeley, we are always trying to stay on top of emerging trends in parking and transportation, and by incorporating smart technologies, our campus can serve as a test bed for new technologies that can be put into operation immediately,” said Seamus Wilmot, Director of Parking and Transportation, UC Berkeley. “Our partnership with NTT and Dell Technologies makes us more digitally-enabled and provides a better understanding for alleviating the root causes of traffic issues. These technologies will help us solve how to manage the curb space at an area that has been challenging for our students, faculty, staff and partners.”
As part of the pilot, NTT and Dell Technologies will implement smart IoT, safety and security innovations that support UC Berkeley’s Parking and Transportation Department, such as real-time alerts and traffic statistics that improve predictions and outcomes. With quantifiable data, UC Berkeley can curb congestion caused by events, ride share traffic, delivery vehicles and transit operations.
The pilot program is designed to provide automated deployment and operation of necessary information and communications technology (ICT) resources from devices and networks to the cloud. The solution will ensure UC Berkeley can focus on improving traffic conditions through analysis and process more efficiently without worrying about ICT deployment and optimization issues.
“This traffic management pilot program begins UC Berkeley’s transformation to a Connected Campus,” said Akira Shimada, Senior Executive Vice President, NTT. “Connected Campuses of the future will offer endless possibilities—for safety, crowd control, traffic and facilities management. UC Berkeley is just getting started, but as a world renowned forward-thinking academic and research University, they see the potential to improve the campus experience and operations using data and smart technologies.”
NTT, along with its operating companies, will deploy its Accelerate Smart solution, which is a secure, distributed network as a platform solution built on NTT’s innovative Cognitive Foundation™ architecture. It enables remote creation, management and operation of information and communications technology resources, from devices and networks to the cloud. It also incorporates hyperconverged infrastructure and IoT gateways from Dell Technologies, as well as virtualization software hosting predictive analytics applications from VMware.
“When we leverage longstanding relationships with great partners like NTT, our joint customers can transform the way they do business,” said Denise Millard, Senior Vice President, Global Alliances, Dell Technologies. “Together we are able to provide customers like UC Berkeley with new tools to leverage data in meaningful ways and make decisions faster to ultimately improve the experience of those on campus.”
Following the initial pilot, UC Berkeley, NTT and Dell Technologies plan to evaluate viability to extend the pilot and potentially add additional locations and use cases on campus. To learn more about the NTT accelerating smart solutions, visit NTT DATA’s website and watch the Accelerate Smart case study with the city of Las Vegas on YouTube .
About NTT
NTT believes in resolving social issues through our business operations by applying technology for good. We help clients accelerate growth and innovate for current and new business models. Our services include digital business consulting, technology and managed services for cybersecurity, applications, workplace, cloud, data center and networks all supported by our deep industry expertise and innovation.
As a top 5 global technology and business solutions provider, our diverse teams operate in 88 countries and regions and deliver services to over 190 of them. We serve 85% of Fortune Global 100 companies and thousands of other clients and communities around the world.
For more information on NTT, visit www.global.ntt/
.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200518005333/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
IQM Named a Major Player in the IDC MarketScape: Worldwide Quantum Computing 2026 Vendor Assessment29.6.2026 09:00:00 CEST | Press release
IQM today announced it has been named a Major Player in the IDC MarketScape: Worldwide Quantum Computing 2026 Vendor Assessment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260629748732/en/ IQM named a major player in the IDC MarketScape IQM believes this recognition comes as institutions worldwide move quantum computing out of shared cloud access and into infrastructure they own and operate themselves. IQM calls this Production Quantum: full-stack, open-architecture superconducting systems deployed on premises, inside customers' own data centers and HPC environments, where organizations own the hardware, build internal expertise, and run quantum processors alongside their existing classical infrastructure. According to the IDC MarketScape, "For institutions building long-term quantum programs, this means the workflows and intellectual property developed on IQM hardware remain portable." The report further advises: "Consi
Zambon Announces Positive CHMP Opinion for Hopledo® (IPX203) for Adults with Parkinson’s Disease and Moderate to Severe Motor Fluctuations29.6.2026 09:00:00 CEST | Press release
Positive CHMP opinion is based on data from the Phase 3 RISE-PD trial, which demonstrated significantly more “Good ON” time with fewer daily doses compared with immediate-release levodopa/carbidopa More than one million people are living with Parkinson’s disease in the European Union, and over 80% experience motor fluctuations during the course of their disease, highlighting the need for additional treatment options Hopledo® contains a unique formulation combining immediate-release granules and extended-release pellets, providing both a rapid onset of action and a longer duration of effect, sustaining the levodopa therapeutic effect for a longer period of time If approved, Zambon expects to make Hopledo® progressively available to patients with Parkinson’s disease across Europe starting October 2026 Zambon today announced that the Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of a marketing authorization by the European M
Enhertu® Approved in the EU as First Tumor Agnostic HER2 Directed Therapy and Antibody Drug Conjugate for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors29.6.2026 08:30:00 CEST | Press release
Approval based on three phase 2 trials of Daiichi Sankyo and AstraZeneca’s Enhertu that demonstrated clinically meaningful responses across a broad range of tumors Enhertu now approved for six indications in the EU Enhertu® (trastuzumab deruxtecan) has been approved in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinion of the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on results from subgroups of patients with HER2 positive (IHC 3+) tumors across thr
Beerenberg Prevails in Patent Case Against Aspen Aerogels29.6.2026 07:00:00 CEST | Press release
The ruling confirms that Beerenberg did not infringe Aspen Aerogels’ patents. The Korean Patent Court has invalidated three of Aspen Aerogels’ patents related to improved hydrophobic aerogel material. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260628192007/en/ Beerenberg delivers high-end insulation solutions built for performance, reliability, and long-term value. (Photo: Beerenberg) The ruling confirms the conclusion of the Intellectual Property Trial and Appeal Board (IPTAB) that the patents did not meet the necessary requirements for patentability. Beerenberg, which specializes in high-end insulation products, welcomes the court’s decision. “We are pleased that the case has now been concluded and that any uncertainty regarding the infringement claims has been removed,” says CEO Arild Apelthun. About Beerenberg Beerenberg has delivered cost-efficient solutions to a wide range of industrial enterprises for 49 years. Th
Seiden Law LLP States: Cambodian Businessman Leak Yim, Wrongfully Accused in Thailand, Seeks Redress in U.S. Court29.6.2026 06:00:00 CEST | Press release
Seiden Law LLP (“Seiden Law”), legal counsel for Mr. Leak Yim, a Cambodia national, and his family, announces the filing of an application in U.S. federal district court in Washington D.C., seeking court-ordered discovery to uncover the false and misleading information that may have led to mistaken prosecution in Thailand of Mr. Yim as well as his unwarranted identification to Congress as being associated with scam centers in Asia. 28 U.S.C. § 1782 (“1782”) provides powerful evidence-gathering remedies, permitting an applicant to obtain evidence in the United States to assist international proceedings. Seiden Law, a U.S. law firm with significant experience in 1782 cases, has filed this application to compel production of documents and sworn testimony from persons in the U.S. that will shed light on the circumstances surrounding recent actions against Mr. Yim. “Mr. Yim and his young family are the apparent victims of guilt by association and political persecution,” said Robert Seiden,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom